These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 610354)

  • 1. Treating severe maladjustment with pipamperone (Dipiperon).
    Noordhuizen GJ
    Acta Psychiatr Belg; 1977; 77(6):754-60. PubMed ID: 610354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pipamperone (Dipiperon) in the treatment of behaviour disorders. A large-scale multicentre evaluation.
    Deberdt R
    Acta Psychiatr Belg; 1976; 76(1):157-66. PubMed ID: 970185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective evaluation of pipamperone (Dipiperon) in the treatment of behavioural deviations in severely mentally handicapped.
    Haegeman J; Duyck F
    Acta Psychiatr Belg; 1978; 78(2):392-8. PubMed ID: 354326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Character neuroses and behavioural disorders in children: their treatment with pipamperone (Dipiperon). A clinical study.
    Van Renynghe de Voxvrie G; De Bie M
    Acta Psychiatr Belg; 1976; 76(4):688-95. PubMed ID: 1020694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pipamperone (Dipiperon), a useful sedative neuroleptic drug in troublesome chronic psychotic patients.
    Squelart P; Saravia J
    Acta Psychiatr Belg; 1977; 77(2):284-93. PubMed ID: 906888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preliminary clinical observations on a new butyrophenone derivative: Dipiperon on Pipamperone (R-3345)].
    Madalena JC
    Hospital (Rio J); 1967 Jan; 71(1):73-8. PubMed ID: 5302873
    [No Abstract]   [Full Text] [Related]  

  • 7. [Character disorders and their treatment by pipamperone].
    Fouks ; Périvier ; Houssalt ; Gilbert ; Ferragu
    Ann Med Psychol (Paris); 1968 Feb; 1(2):255-8. PubMed ID: 5651948
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pipamperone and the treatment of impulsive aggressive behaviour].
    Klaassen AA
    Tijdschr Psychiatr; 2008; 50(3):179-83. PubMed ID: 18324605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep disorders in patients with severe mental depression: double-blind placebo-controlled evaluation of the value of pipamperone (Dipiperon).
    Ansoms C; Backer-Dierick GD; Vereecken JL
    Acta Psychiatr Scand; 1977 Feb; 55(2):116-22. PubMed ID: 320830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pipamperone (Dipiperon, R3345) in troublesome mental retardates: a double-blind placebo controlled cross-over study with long-term follow-up.
    van Hemert JC
    Acta Psychiatr Scand; 1975 Oct; 52(4):237-45. PubMed ID: 1103575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical effects of the butyrophenones. Floropipamide (Dipiperon), methylperon (Buronil), trifluperidol (Psicoperidol)].
    Kristjansen P
    Nord Psykiatr Tidsskr; 1968; 22(3):235-48. PubMed ID: 5711258
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of lisinopril or lisinopril/hydrochlorothiazide compared with adjusting of previous medication and intensifying non-pharmacological treatment in patients with mild to moderate hypertension.
    Keinänen-Kiukaanniemi S; Rasmusen M; Pekkarinen T; Pitkäjärvi T; Romo M; Takala J
    Arzneimittelforschung; 1997 Feb; 47(2):144-50. PubMed ID: 9079233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sedalium in psychiatry within its tranquilizing and neuroleptic boundaries].
    Volmat R; Beaudouin JL; Allers G; Vittouris N; Dufay F; Bizouard P
    Encephale; 1972; 61(2):163-82. PubMed ID: 4634905
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical evaluation of a butyrophenone derivative, methylperidol, in 40 cases of schizophrenia and other psychoses].
    Vinci M
    Osp Psichiatr; 1971; 39(2):399-407. PubMed ID: 4948707
    [No Abstract]   [Full Text] [Related]  

  • 15. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [AHR-2277: a new major neuroleptic with minimal neurological side-effects].
    Denber HC
    Ann Med Psychol (Paris); 1973 Jan; 1(1):131-8. PubMed ID: 4723202
    [No Abstract]   [Full Text] [Related]  

  • 17. [Atypical neuroleptics in dementia. Managing behavioral disorders early and efficiently].
    MMW Fortschr Med; 2002 Mar; 144(10):60-1. PubMed ID: 11928271
    [No Abstract]   [Full Text] [Related]  

  • 18. [Side effects of methylperone in long-term therapy up to 8 years].
    Kirkegaard G; Kirkegaard A
    Arzneimittelforschung; 1974 Aug; 24(8):1115-7. PubMed ID: 4213783
    [No Abstract]   [Full Text] [Related]  

  • 19. Pilot study on the use of AL-1021 in the treatment of chronic schizophrenia.
    Angus JW; Go SH; Simpson GM
    Curr Ther Res Clin Exp; 1969 Dec; 11(12):779-83. PubMed ID: 4984043
    [No Abstract]   [Full Text] [Related]  

  • 20. [Amitriptyline hydrochloride in the treatment of anxiety and insomnia and as a tranquilizer].
    Aurón Zaltzman D
    Neurol Neurocir Psiquiatr; 1976; 17(3):165-9. PubMed ID: 1004682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.